- funding probability score
- total disclosed funding
- last round valuation estimate
- disclosed funding rounds
- latest round
- latest funding stage
- next round estimate
- development stage
- number of investors
- number of competitors
- monthly web visits
- twitter followers
- Anagenesis Biotechnologies is a preclinical‐stage stem cell-based company focused on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs.
Anagenesis Biotechnologies secured two private investments from the AFM (French muscular dystrophy association) to develop applications in the skeletal muscle therapeutic area and from Cap Innov'Est. Anagenesis Biotechnologies aim is to become the world leader in muscle-related diseases.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats